Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook
Moderna also missed revenue and earnings expectations for the quarter. Source link
Read MoreModerna also missed revenue and earnings expectations for the quarter. Source link
Read MoreA number of U.S. health care and pharmaceutical stocks had big gains last week, and analysts say they've got further
Read MoreThe widely held ARK Innovation ETF and the Technology Select Sector SPDR Fund aren't showing meaningful outflows so far this
Read MoreThe FDA pushed back against two independent studies that found the new boosters don't trigger a better immune response than
Read MoreDruckenmiller opened positions in several beaten-down growth stocks as they hit their lows of the year. Source link
Read MoreBritain on Monday became the first country in the world to approve a dual Covid-19 vaccine, which tackles both the
Read MoreDozens of companies report earnings next week, but it may be big economic data, like Friday's jobs report, that takes
Read MoreNovavax's new Covid vaccine is perfect for people scared of mRNA tech. Here's why experts say many of them still
Read MoreUpdating the shots to target omicron could provide more durable protection against the virus, though the data right now is
Read More